Steno-Clinical-REsearch-ENtrance (SCREEN)

SDCC has developed a framework to facilitate life science collaboration with an emphasis on professional and agile processes. This means that we have a one-point-of-entry for all clinical research collaborations, providing an easy and fast way to contact us.

The committee for SCREEN will receive and answer all new queries for collaboration and review them for the following criteria:

  • That the research is relevant to the strategy at SDCC with an emphasis on world-class patient-centered diabetes care.
  • That the available resources and patient population match the research objectives and enrollment criteria.
  • That there is synergy between clinical research at SDCC.

It is no longer possible to initiate external collaborations with individual researchers outside of SCREEN. All clinical trials initiated and conducted at SDCC need to go through the SCREEN process.

If your participants need to sign an informed consent, then it’s likely that your project needs to be approved by SCREEN. If in doubt, contact Michelle Ellefson, Head of Research & Innovation at SDCC.

Applicants will be notified within 7 business days of the SCREEN SC decision.

SCREEN Steering Committee Members

Birgitte Brock, Head of Research, chairman
Peter Rossing, Head of Complications Research
Anne Mette Rosenfalck, Head of Clinic
Kirsten Nørgaard, Clinician and Principal Investigator
Tina Vilsbøll, Clinician and Principal Investigator
Ingrid Willaing, Head of Diabetes Management Research
Evy Connie Ottesen, Head of CoreLab
Michelle Ellefson, Head of Research and Innovation 


SCREEN 2019 Deadlines and SC Meetings

Steering Committee Meetings 
Deadline for material to be sent
​January​21 December
February18 January
March15 February
April22 March
May 19 April
June20 May
August1 August
September28 August
October17 October
November17 October
December28 November

A more detailed description of SCREEN can be found in the white paper below:

Responsible editor